AbbVie
ABBV
#25
Rank
C$740.52 B
Marketcap
C$418.94
Share price
-0.59%
Change (1 day)
27.42%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): C$18.04 Billion

According to AbbVie's latest financial reports the company's current earnings are C$66.01 Billion. In 2025 the company made an earning of C$9.43 Billion, an increase over its 2024 earnings that were of C$5.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$18.04 B91.24%
2025 C$9.43 B77.53%
2024 C$5.31 B-40.54%
2023 C$8.94 B-53.62%
2022 C$19.28 B3.76%
2021 C$18.58 B282.25%
2020 C$4.86 B-59.67%
2019 C$12.05 B62.13%
2018 C$7.43 B-32.74%
2017 C$11.05 B-1.99%
2016 C$11.27 B18.65%
2015 C$9.50 B180.5%
2014 C$3.38 B-55.57%
2013 C$7.62 B-6.86%
2012 C$8.19 B56.05%
2011 C$5.24 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.96 B-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.74 B 171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.81 B-13.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$0.63 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$3.63 Billion-119.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.21 B-11.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$21.58 B 17.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$10.23 B-44.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.23 B-93.27%๐Ÿ‡บ๐Ÿ‡ธ USA